Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

GSK

Gsk (GSK)

Gsk Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:GSK
DataHoraFonteTítuloCódigoCompanhia
18/09/202410:00Alliance NewsAlliance NewsGSK reaches further two settlements regarding ZantacLSE:GSKGsk Plc
18/09/202409:20RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
17/09/202405:18Alliance NewsAlliance NewsGSK says Blenrep combinations accepted for review in JapanLSE:GSKGsk Plc
17/09/202403:00RNS Regulatory NewsGSK PLC Japan Filing Acceptance: Blenrep Multiple MyelomaLSE:GSKGsk Plc
16/09/202414:04PR Newswire (US)Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles RiskLSE:GSKGsk Plc
13/09/202405:14Alliance NewsAlliance NewsGSK myeloma treatment given breakthrough therapy designation in ChinaLSE:GSKGsk Plc
13/09/202403:00RNS Regulatory NewsGSK PLC China Breakthrough Therapy Designation for BlenrepLSE:GSKGsk Plc
12/09/202411:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
12/09/202404:31Alliance NewsAlliance NewsTOP NEWS: GSK welcomes positive findings on possible flu treatmentLSE:GSKGsk Plc
12/09/202403:00RNS Regulatory NewsGSK PLC Positive mRNA flu vaccine Phase II headline dataLSE:GSKGsk Plc
11/09/202411:30RNS Regulatory NewsGSK PLC Change of Registered OfficeLSE:GSKGsk Plc
11/09/202405:55Alliance NewsAlliance NewsGSK stresses need for innovation as herpes vaccine fails to progressLSE:GSKGsk Plc
11/09/202403:00RNS Regulatory NewsGSK PLC Update on phase I/II therapeutic HSV vaccine trialLSE:GSKGsk Plc
09/09/202418:02Alliance NewsAlliance NewsTRADING UPDATES: Live Co fails to reach agreement with creditorLSE:GSKGsk Plc
09/09/202410:30RNS Regulatory NewsGSK PLC Depemokimab late-breaking data presented at ERSLSE:GSKGsk Plc
06/09/202405:38Alliance NewsAlliance NewsGSK hails positive results of Nucala clinical trials in lung diseaseLSE:GSKGsk Plc
06/09/202403:00RNS Regulatory NewsGSK PLC Positive Phase III results for Nucala in COPDLSE:GSKGsk Plc
02/09/202411:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
29/08/202406:37Alliance NewsAlliance NewsTOP NEWS: GSK hails EU approval of RSV jab Arexy for 50-59 year oldsLSE:GSKGsk Plc
29/08/202403:00RNS Regulatory NewsGSK PLC EMA approval on Arexvy for 50-59 at riskLSE:GSKGsk Plc
28/08/202405:14Alliance NewsAlliance NewsTOP NEWS: GSK hails approval in Japan; US court decision on ZantacLSE:GSKGsk Plc
28/08/202403:10RNS Regulatory NewsGSK PLC SENKU Designation for Bepirovirsen in JapanLSE:GSKGsk Plc
28/08/202403:05RNS Regulatory NewsGSK PLC Nucala approved in Japan for use in CRSwNPLSE:GSKGsk Plc
20/08/202405:29Alliance NewsAlliance NewsTOP NEWS: GSK celebrates US FDA breakthrough therapy designationLSE:GSKGsk Plc
20/08/202403:00RNS Regulatory NewsGSK PLC B7-H3 ADC US FDA Breakthrough Therapy DesignationLSE:GSKGsk Plc
16/08/202403:00Alliance NewsAlliance NewsTOP NEWS: GSK celebrates Florida state court ruling in Zantac caseLSE:GSKGsk Plc
06/08/202405:06Alliance NewsAlliance NewsGSK celebrates Illinois jury verdict on Zantac in favour of companyLSE:GSKGsk Plc
02/08/202403:00RNS Regulatory NewsGSK PLC FDA Expands Jemperli ApprovalLSE:GSKGsk Plc
02/08/202402:54Alliance NewsAlliance NewsGSK celebrates US FDA backing for expanded use of cancer drug JemperliLSE:GSKGsk Plc
31/07/202405:34Alliance NewsAlliance NewsTOP NEWS: GSK's raised outlook clouded by weak vaccines, Shingrix dropLSE:GSKGsk Plc
 Apresentando as notícias mais relevantes sobre:LSE:GSK